theresasresearch.bsky.social
@theresasresearch.bsky.social
Reposted
@ourmbclife.bsky.social latest is with Josh Newby of @theresasresearch.bsky.social where he offers hope, big plans + a reminder of where we were & where we can be #cansky #oncsky 🎧 podcasts.apple.com/us/podcast/o...
S10 E02 Trailblazers: Josh Newby & Theresa's Research Foundation
Podcast Episode · Our MBC Life · 04/02/2025 · 37m
podcasts.apple.com
April 12, 2025 at 1:20 PM
Reposted
📢 Big news from@theresasresearch.bsky.social for 2025! Download & listen to this #OMBCL chat with founder Josh Newby about what’s ahead. #BCMHouston #metavivor #mbcalliance #sitemancancer
🎧 Listen (all channels) or 🔗 buff.ly/oKyIj8H
#MBC #research #PatientAdvocacy #science #BCSM #CanSky
April 2, 2025 at 10:07 PM
Reposted
Josh Newby from @theresasresearch.bsky.social is doubling down on a cure for MBC. Here he talks about the work #TRF is doing & what a “cure” for MBC means to him, the scientific & the MBC community.
🎧 Listen (all channels) or 🔗 buff.ly/owFqMHB
#BCSM #TRF #MBC #research #PatientAdvocacy
April 4, 2025 at 3:16 PM
Reposted
Josh Newby from @theresasresearch.bsky.social dispels why it wouldn't make sense for a cure for cancer to be withheld from the cancer community.
o him, the scientific & MBC community.
🎧 Listen (all channels) or 🔗 buff.ly/fUWa3Gp
#BCSM #TRF #MBC #research #PatientAdvocacy #CanSky
April 8, 2025 at 1:08 PM

We are launching a webinar series with The Breast Cancer Program @sitemancenter.bsky.social

Below is the link to register. Registration is free and the Webinar will also include a town hall. All those impacted by MBC are welcome to attend.

Registration Link:

wustl-hipaa.zoom.us/meeting/regi...
March 19, 2025 at 7:16 PM
Reposted
🎥 @naborala.bsky.social of @mdanderson.bsky.social discusses Phase II trial findings on neoadjuvant enzalutamide & paclitaxel in LAR-enriched #TNBC. Promising response rates & IHC/RNA sequencing alignment:

➡️ https://buff.ly/4iRnvIj ⬅️

@sabcs.bsky.social #SABCS24 #BreastCancer
Phase II trial results on enzalutamide and paclitaxel in LAR-enriched TNBC - VJOncology
Bora Lim, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, provides a brief overview on the Phase...
buff.ly
December 30, 2024 at 3:54 PM
Reposted
The first panel focuses on approaches to interpreting interim overall survival. #FriendsAM24
November 12, 2024 at 3:52 PM
Reposted
Our lunch keynote is between Friends’ CEO Jeff Allen and NCI Director Kimryn Rathmell. #FriendsAM24
November 12, 2024 at 6:31 PM
Reposted
Our final panel focuses on how we can integrate ctDNA into prospective clinical trials to support intermediate endpoint validation. #FriendsAM24
November 12, 2024 at 7:14 PM
Reposted
Our final panel focuses on how we can integrate ctDNA into prospective clinical trials to support intermediate endpoint validation. #FriendsAM24
November 12, 2024 at 7:15 PM